The greatest diagnostic product in the world wouldn’t mean much if it couldn’t get through the rigorous vettin…
Multiplex Tests Assess Immunogenicity for Vaccine Development Efforts
A look at human papillomavirus and Staphylococcus aureus vaccine studies by the numbers As the majority of nov…
Webinar: Kidney Function Study Suggests Biomarkers Associated with IgA Nephropathy
xMAP® multiplex assays were used to interrogate samples In work powered in part by Luminex’s xMAP® Technology,…
Luminex Licensed Technologies Partner Spotlight: MilliporeSigma
600+ validated antibody pairs for analytes galore When commercially available multiplex kits are not optimally…
The Faces of Luminex: Meghan Procopio, Global Sales
When Luminex began selling directly to customers instead of solely through distributors, we had to build not o…
Webinar: Multiplex Assay Offers Improved Freshwater Toxicity Testing
Ecotoxicity program turns to xMAP® Technology for multi-biomarker detection A vital tool for assessing the tox…
Luminex Licensed Technologies Partner Spotlight: Radix BioSolutions
Custom assay development At Radix, scientists design and manufacture Luminex assays so their customers can foc…
The Faces of Luminex: Victoria Gutierrez, Global Events
Successful trade shows and events require strong leadership to align tactics with the strategic initiatives of…
Webinar: xMAP® Technology Drives Development of Prostate Cancer Detection Assay
Better test accuracy reduces the need for invasive biopsy procedures For a startup company striving to de…
MLO Article: New Testing Guidelines and Studies for C. difficile
Earn continuing education credits in this review of screening, the NAP1 marker, and more A new continuing educ…